Caregen Co., Ltd. (KOSDAQ: 214370)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,950
+2,550 (10.45%)
Dec 20, 2024, 9:00 AM KST
-7.23%
Market Cap 1.32T
Revenue (ttm) 78.67B
Net Income (ttm) 35.79B
Shares Out 48.99M
EPS (ttm) 728.00
PE Ratio 37.02
Forward PE 29.74
Dividend 880.00 (3.27%)
Ex-Dividend Date Jun 27, 2024
Volume 449,457
Open 24,450
Previous Close 24,400
Day's Range 24,400 - 27,600
52-Week Range 14,850 - 29,300
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 5, 2025

About Caregen

Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. The company offers filler products under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name. It is also developing medicines for COVID-19 treatment, wet macular degeneration, dry macular degeneration, antivira... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 180
Stock Exchange KOSDAQ
Ticker Symbol 214370
Full Company Profile

Financial Performance

In 2023, Caregen's revenue was 79.21 billion, an increase of 14.63% compared to the previous year's 69.10 billion. Earnings were 39.93 billion, an increase of 46.44%.

Financial Statements

News

Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen

Akums Drugs and Pharmaceuticals saw a 5% jump in its stock price after signing an exclusive Master Sales Agreement with South Korea-based Caregen Co., Ltd. The deal gives Akums exclusive rights to pac...

4 weeks ago - Business Upturn

Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion

Akums Drugs and Pharmaceuticals Ltd., a leading name in the pharmaceutical industry, has signed an exclusive Master Sales Agreement with South Korea’s Caregen Co., Ltd. This partnership grants Akums e...

4 weeks ago - Business Upturn